This article was originally published in The Tan Sheet
Executive Summary"Striking reduction in mortality" found in patients with acute myocardial infarction treated with emergency aspirin before, versus those treated after, initiation of thrombolysis infusion, according to Feb. 15 American Journal of Cardiology. Dov Freimark, MD, et al., Tel-Aviv University, found that after 30 days, mortality of early aspirin users was 3.3% vs. 7.3% for late users; after one year, it was 5% and 10.6%, respectively. Freimark et al. studied 1,200 AMI patients from the Argatroban in Acute MI-2 trial; daily dose of 160 mg aspirin was initiated before or after beginning thrombolytic therapy...
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.